Stephens initiates coverage on ADC Therapeutics (ADCT), highlighting Zynlonta's potential in second-line DLBCL and a ...

Cardiff has a cash runway of 5-6 quarters, but will need additional funding, potentially leading to significant shareholder ...

(Reuters) - A Russian guided bomb attack on Ukraine's southeastern city of Zaporizhzhia on Thursday killed four people and ...

The Post Graduate Institute of Medical Education and Research (PGIMER) kicked off the Global International Oncology Summit ...

In a tough fundraising space, cell therapy biotechs pursuing autoimmune indications review staffing to ensure the right ...

Fintel reports that on November 8, 2024, Stephens & Co. initiated coverage of Pyxis Oncology (NasdaqGS:PYXS) with a ...

While some of the initial excitement around immunotherapies has waned, companies—particularly smaller biotechs—are developing ...

Though the effect on physician reimbursement will vary, ASCO estimates a 4% decrease for medical oncology, a 3.25% decrease for radiation oncology and a 3.6% decrease for gynecologic oncology in 2025.

Sanofi is conducting the two-part multicenter, randomized, open-label, controlled, parallel-group study (NCT04643002) to evaluate the safety, efficacy, pharmacokinetics and biomarker data of ...

Erin Wright, M.D., is the new chairholder of the Jeffrey A. Barbour Chair for Pediatric Hematology/Oncology Research and ...

In a report released today, Marc Frahm from TD Cowen maintained a Buy rating on Cardiff Oncology (CRDF – Research Report). The ...

Mercy Health — Lorain is expanding its radiation oncology services for breast cancer patients, adding prone positioning to its treatment offerings, according to a news release. Prone breast ...